Next |
home / stock / rvvtf / rvvtf message board
Subject | By | Source | When |
---|---|---|---|
https://sih-st-charts.stocktwits-cdn.com/fit-in/500x0/filters:quality(75)/p | JoeBenson | investorshub | 07/06/2023 8:20:10 PM |
Still pumping LOL | tripmcneely | investorshub | 07/06/2023 7:46:25 PM |
https://www.reddit.com/r/$RVVTF/comments/14scuuy/as promised/?utm source=share&ut | Gatorca | investorshub | 07/06/2023 5:12:27 PM |
Looks like our next event will be on | Snoop_dog | investorshub | 07/06/2023 4:57:08 PM |
Yes you are correct | govprs | investorshub | 07/06/2023 4:22:23 PM |
Sure, after a 1 for 250 R/S. This | PennyWorld | investorshub | 07/06/2023 4:17:00 PM |
Its was all a scam look at the | govprs | investorshub | 07/06/2023 4:15:31 PM |
Bucillamine is dead .... over .... just like | Jack Torrance | investorshub | 07/06/2023 3:59:40 PM |
They just did a 4.3 mil raise at | govprs | investorshub | 07/06/2023 3:56:46 PM |
$RVVTF has 356 million in O/S and only | PennyWorld | investorshub | 07/06/2023 3:29:22 PM |
Translationbucillamine does not work on Covid-19. | JoeBenson | investorshub | 07/06/2023 3:25:27 PM |
Very interesting video, it tells me a lot, | Ecomike | investorshub | 07/06/2023 3:08:22 PM |
LoL | govprs | investorshub | 07/06/2023 2:51:15 PM |
Interesting morning here. Every low life short seller | Ecomike | investorshub | 07/06/2023 2:37:28 PM |
We're basically done here. For me it doesn't | Spumoni | investorshub | 07/06/2023 1:50:47 PM |
The Study did not achieve statistical significance on | greatnessawaits | investorshub | 07/06/2023 1:34:35 PM |
Revive Therapeutics Announces Results of Phase 3 Clinical | powerbattles | investorshub | 07/06/2023 1:24:05 PM |
And now there is a Bucillamine video Jul | Gatorca | investorshub | 07/05/2023 1:59:33 PM |
that's about it | Hotel Delta | investorshub | 07/01/2023 1:25:23 PM |
#Bucillamine | Cool888 | investorshub | 07/01/2023 12:50:09 PM |
News, Short Squeeze, Breakout and More Instantly...
Revive Therapeutics Ltd. Company Name:
RVVTF Stock Symbol:
OTCMKTS Market:
TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, a...
TORONTO, March 19, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, a...
TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, a...